NCT06506305View on ClinicalTrials.gov

Clinical Study of FB1001 in Patients

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

59

Participants

Timeline

Start Date

August 15, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

October 31, 2026

Conditions

Optic NeuropathyNAION - Non-Arteritic Ischemic Optic NeuropathyAPAC - Acute Primary Angle ClosureGlaucoma, Angle-Closure

Interventions

DRUG

FB1001

Intravitreal (IVT) injection

Trial Locations (1)

200080

Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai

Sponsors

Collaborators (1)

4B Technologies Limited

All Listed Sponsors

collaborator

4B Technologies Limited

INDUSTRY

lead

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

OTHER